The magic pill behind this pharma stock’s 2x growth in 12 months

A brilliant run

Riding on the heels of strong financials, Gujarat Themis has grown around 2.6x in the past 12 months (as of May 18, 2024).

The growth fuel

It used to solely work as a contract manufacturer with fixed profit margins. However, its financials improved when it started selling directly to large pharma clients

Contd…

Its revenue and profit margins improved significantly, and have been on a consistent rise since FY20.

However…

Don’t rush to invest yet. D-street is ignoring some risks. Read the full article for free and uncover these risks. Click on the link below.